Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins

Abstract

As with other pathogen reduction technologies, the Mirasol process resulted in some loss of coagulation factor activity. For most Mirasol-treated units and for most of the tested factors this is unlikely to have clinical impact, but trials are required to demonstrate this.